{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:35:06Z","timestamp":1793140506111,"version":"4.5.0"},"reference-count":113,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Democritus University of Thrace, Greece","award":["80895"],"award-info":[{"award-number":["80895"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.jaut.2019.102305","type":"journal-article","created":{"date-parts":[[2019,7,20]],"date-time":"2019-07-20T07:19:32Z","timestamp":1563607172000},"page":"102305","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Autoinflammation: Lessons from the study of familial Mediterranean fever"],"prefix":"10.1016","volume":"104","author":[{"given":"Panagiotis","family":"Skendros","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charalampos","family":"Papagoras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Mitroulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Ritis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2019.102305_bib1","doi-asserted-by":"crossref","first-page":"e297","DOI":"10.1371\/journal.pmed.0030297","article-title":"A proposed classification of the immunological diseases","volume":"3","author":"McGonagle","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.jaut.2019.102305_bib2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/path.4812","article-title":"The burgeoning field of innate immune-mediated disease and autoinflammation","volume":"241","author":"Peckham","year":"2017","journal-title":"J. Pathol."},{"key":"10.1016\/j.jaut.2019.102305_bib3","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0092-8674(00)80721-7","article-title":"Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes","volume":"97","author":"McDermott","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.jaut.2019.102305_bib4","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ejim.2010.03.005","article-title":"Targeting IL-1beta in disease; the expanding role of NLRP3 inflammasome","volume":"21","author":"Mitroulis","year":"2010","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.jaut.2019.102305_bib5","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/ni.3777","article-title":"The monogenic autoinflammatory diseases define new pathways in human innate immunity and inflammation","volume":"18","author":"Manthiram","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2019.102305_bib6","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1074-7613(04)00046-9","article-title":"NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder","volume":"20","author":"Agostini","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2019.102305_bib7","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev.immunol.25.022106.141627","article-title":"Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*)","volume":"27","author":"Masters","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jaut.2019.102305_bib8","first-page":"469","article-title":"Treating inflammation by blocking interleukin-1 in humans, Semin","volume":"25","author":"Dinarello","year":"2013","journal-title":"Immunology"},{"key":"10.1016\/j.jaut.2019.102305_bib9","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jpeds.2019.02.039","article-title":"The changing concepts regarding the mediterranean fever gene: toward a spectrum of pyrin-associated autoinflammatory diseases with variable heredity","volume":"209","author":"Boursier","year":"2019","journal-title":"J. Pediatr."},{"key":"10.1016\/j.jaut.2019.102305_bib10","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1002\/art.24458","article-title":"Familial mediterranean Fever in the world","volume":"61","author":"Ben-Chetrit","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2019.102305_bib11","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1136\/annrheumdis-2015-208690","article-title":"EULAR recommendations for the management of familial Mediterranean fever","volume":"75","author":"Ozen","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2019.102305_bib12","first-page":"A666","article-title":"Cost of familial mediterranean fever (fmf) disease in Turkey, value health","volume":"18","author":"Aksu","year":"2015","journal-title":"J. Int. Soc. Pharmacoeconomics Outcomes Res."},{"key":"10.1016\/j.jaut.2019.102305_bib13","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nrrheum.2010.181","article-title":"Chronic inflammation in FMF: markers, risk factors, outcomes and therapy","volume":"7","author":"Ben-Zvi","year":"2011","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jaut.2019.102305_bib14","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nrrheum.2013.174","article-title":"A clinical guide to autoinflammatory diseases: familial Mediterranean fever and next-of-kin","volume":"10","author":"Ozen","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jaut.2019.102305_bib15","series-title":"Textb. Autoinflammation","first-page":"293","article-title":"Familial mediterranean fever","author":"Padeh","year":"2019"},{"key":"10.1016\/j.jaut.2019.102305_bib16","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1136\/annrheumdis-2014-205958","article-title":"Neutrophil extracellular traps regulate IL-1\u03b2-mediated inflammation in familial Mediterranean fever, Ann","volume":"75","author":"Apostolidou","year":"2016","journal-title":"Rheum. Dis."},{"key":"10.1016\/j.jaut.2019.102305_bib17","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.jaci.2017.02.021","article-title":"Regulated in development and DNA damage responses 1 (REDD1) links stress with IL-1\u03b2-mediated familial Mediterranean fever attack through autophagy-driven neutrophil extracellular traps","volume":"140","author":"Skendros","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jaut.2019.102305_bib18","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.jaci.2017.09.007","article-title":"The Editors' Choice. Lessons from familial Mediterranean fever: REDD1 is a novel regulator of stress-induced neutrophilic inflammation","volume":"140","author":"Akdis","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jaut.2019.102305_bib19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/ng0997-25","article-title":"A candidate gene for familial Mediterranean fever","volume":"17","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jaut.2019.102305_bib20","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0092-8674(00)80539-5","article-title":"Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. The International FMF Consortium","volume":"90","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.jaut.2019.102305_bib21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.gene.2017.05.013","article-title":"MEFV mutations and their relation to major clinical symptoms of Familial Mediterranean Fever","volume":"626","author":"Cekin","year":"2017","journal-title":"Gene"},{"key":"10.1016\/j.jaut.2019.102305_bib22","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.gene.2011.10.012","article-title":"Homozygous M694V as a risk factor for amyloidosis in Turkish FMF patients","volume":"492","author":"Akpolat","year":"2012","journal-title":"Gene"},{"key":"10.1016\/j.jaut.2019.102305_bib23","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/sj.ejhg.5200170","article-title":"Phenotype-genotype correlation in Jewish patients suffering from familial Mediterranean fever (FMF)","volume":"6","author":"Dewalle","year":"1998","journal-title":"Eur. J. Hum. Genet. EJHG."},{"key":"10.1016\/j.jaut.2019.102305_bib24","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1136\/annrheumdis-2014-206844","article-title":"Evidence-based recommendations for genetic diagnosis of familial Mediterranean fever","volume":"74","author":"Giancane","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2019.102305_bib25","first-page":"72","article-title":"MEFV and SAA1 genotype associations with clinical features of familial Mediterranean fever and amyloidosis in Armenia","volume":"34","author":"Atoyan","year":"2016","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2019.102305_bib26","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1002\/art.22507","article-title":"International study group for phenotype-genotype correlation in familial mediterranean fever, country as the primary risk factor for renal amyloidosis in familial mediterranean fever","volume":"56","author":"Touitou","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2019.102305_bib27","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1136\/ard.2003.009258","article-title":"Non-isotopic RNase cleavage assay for mutation detection in MEFV, the gene responsible for familial Mediterranean fever, in a cohort of Greek patients","volume":"63","author":"Ritis","year":"2004","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2019.102305_bib28","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1136\/ard.62.5.479","article-title":"Familial Mediterranean fever associated pyrin mutations in Greece","volume":"62","author":"Konstantopoulos","year":"2003","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2019.102305_bib29","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1399-0004.2007.00789.x","article-title":"MEFV alterations and population genetics analysis in a large cohort of Greek patients with familial Mediterranean fever","volume":"71","author":"Giaglis","year":"2007","journal-title":"Clin. Genet."},{"key":"10.1016\/j.jaut.2019.102305_bib30","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1399-0004.2007.00948.x","article-title":"Familial Mediterranean Fever in Crete: a genetic and structural biological approach in a population of \u201cintermediate risk","volume":"73","author":"Fragouli","year":"2008","journal-title":"Clin. Genet."},{"key":"10.1016\/j.jaut.2019.102305_bib31","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/j.1469-1809.2008.00471.x","article-title":"The population genetics of familial mediterranean fever: a meta-analysis study","volume":"72","author":"Papadopoulos","year":"2008","journal-title":"Ann. Hum. Genet."},{"key":"10.1016\/j.jaut.2019.102305_bib32","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00296-007-0389-3","article-title":"A novel mutation of the familial Mediterranean fever gene in a Greek family related to a non-classical, variably expressed FMF phenotype","volume":"28","author":"Zonios","year":"2007","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jaut.2019.102305_bib33","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s10620-006-3192-1","article-title":"Increased frequency of mutations in the gene responsible for familial Mediterranean fever (MEFV) in a cohort of patients with ulcerative colitis: evidence for a potential disease-modifying effect?","volume":"51","author":"Giaglis","year":"2006","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.jaut.2019.102305_bib34","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1136\/jmedgenet-2013-101577","article-title":"Inheritance of autoinflammatory diseases: shifting paradigms and nomenclature","volume":"50","author":"Touitou","year":"2013","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.jaut.2019.102305_bib35","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/art.24569","article-title":"Familial Mediterranean fever with a single MEFV mutation: where is the second hit?","volume":"60","author":"Booty","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2019.102305_bib36","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1002\/art.24570","article-title":"Clinical disease among patients heterozygous for familial Mediterranean fever","volume":"60","author":"Marek-Yagel","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2019.102305_bib37","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1093\/rheumatology\/kep121","article-title":"The clinical spectrum of 94 patients carrying a single mutated MEFV allele","volume":"48","author":"Kon\u00e9-Paut","year":"2009","journal-title":"Rheumatol. Oxf. Engl."},{"key":"10.1016\/j.jaut.2019.102305_bib38","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/rheumatology\/kew058","article-title":"Autosomal dominant familial Mediterranean fever in Northern European Caucasians associated with deletion of p.M694 residue-a case series and genetic exploration","volume":"56","author":"Rowczenio","year":"2017","journal-title":"Rheumatol. Oxf. Engl."},{"key":"10.1016\/j.jaut.2019.102305_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055227","article-title":"The contribution of SAA1 polymorphisms to Familial Mediterranean fever susceptibility in the Japanese population","volume":"8","author":"Migita","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2019.102305_bib40","first-page":"271","article-title":"Analysis of SAA1 gene polymorphisms in the Greek population: rheumatoid arthritis and FMF patients relative to normal controls. Homogeneous distribution and low incidence of AA amyloidosis","volume":"14","author":"Mavragani","year":"2007","journal-title":"Amyloid Int. J. Exp. Clin. Investig. Off. J. Int. Soc. Amyloidosis."},{"key":"10.1016\/j.jaut.2019.102305_bib41","first-page":"750","article-title":"TLR2 and TLR4 polymorphisms in familial Mediterranean fever, Hum","volume":"70","author":"Speletas","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.jaut.2019.102305_bib42","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.1007\/s11033-011-1353-6","article-title":"Genetic analysis of C5a receptors in neutrophils from patients with familial Mediterranean fever","volume":"39","author":"Apostolidou","year":"2012","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.jaut.2019.102305_bib43","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1136\/annrheumdis-2017-212515","article-title":"Paediatric Rheumatology International Trials Organisation (PRINTO) and the AIDs Delphi study participants, Consensus proposal for taxonomy and definition of the autoinflammatory diseases (AIDs): a Delphi study","volume":"77","author":"Ben-Chetrit","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2019.102305_bib44","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2019-215048","article-title":"Eurofever registry and the paediatric rheumatology international trials organisation (PRINTO), classification criteria for autoinflammatory recurrent fevers","author":"Gattorno","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2019.102305_bib45","first-page":"387","article-title":"Evidence-based recommendations for the practical management of familial mediterranean fever, semin","volume":"43","author":"Hentgen","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2019.102305_bib46","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/gene.2011.53","article-title":"The regulation of MEFV expression and its role in health and familial Mediterranean fever","volume":"12","author":"Grandemange","year":"2011","journal-title":"Genes Immun."},{"key":"10.1016\/j.jaut.2019.102305_bib47","doi-asserted-by":"crossref","first-page":"9982","DOI":"10.1073\/pnas.0602081103","article-title":"The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1beta production","volume":"103","author":"Chae","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jaut.2019.102305_bib48","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1038\/sj.cdd.4402142","article-title":"The SPRY domain of Pyrin, mutated in familial Mediterranean fever patients, interacts with inflammasome components and inhibits proIL-1beta processing","volume":"14","author":"Papin","year":"2007","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.jaut.2019.102305_bib49","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.immuni.2011.02.020","article-title":"Gain-of-function Pyrin mutations induce NLRP3 protein-independent interleukin-1\u03b2 activation and severe autoinflammation in mice","volume":"34","author":"Chae","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2019.102305_bib50","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1084\/jem.20172060","article-title":"GSDMD is critical for autoinflammatory pathology in a mouse model of Familial Mediterranean Fever","volume":"215","author":"Kanneganti","year":"2018","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2019.102305_bib51","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature13449","article-title":"Innate immune sensing of bacterial modifications of Rho GTPases by the Pyrin inflammasome","volume":"513","author":"Xu","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2019.102305_bib52","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/ni.3457","article-title":"Pyrin inflammasome activation and RhoA signaling in the autoinflammatory diseases FMF and HIDS","volume":"17","author":"Park","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2019.102305_bib53","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/eji.200940025","article-title":"Regulation of the autophagic machinery in human neutrophils","volume":"40","author":"Mitroulis","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jaut.2019.102305_bib54","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3389\/fcell.2018.00109","article-title":"Autophagy in neutrophils: from granulopoiesis to neutrophil extracellular traps","volume":"6","author":"Skendros","year":"2018","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.jaut.2019.102305_bib55","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1083\/jcb.201503023","article-title":"TRIM-mediated precision autophagy targets cytoplasmic regulators of innate immunity","volume":"210","author":"Kimura","year":"2015","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.jaut.2019.102305_bib56","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1080\/15548627.2016.1154254","article-title":"TRIM-directed selective autophagy regulates immune activation","volume":"13","author":"Kimura","year":"2017","journal-title":"Autophagy"},{"key":"10.1016\/j.jaut.2019.102305_bib57","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jaci.2016.05.009","article-title":"Regulation of inflammasomes by autophagy","volume":"138","author":"Saitoh","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jaut.2019.102305_bib58","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/imr.12448","article-title":"Human neutrophils in the saga of cellular heterogeneity: insights and open questions","volume":"273","author":"Scapini","year":"2016","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jaut.2019.102305_bib59","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13059-017-1156-8","article-title":"Genome-wide analysis of differential transcriptional and epigenetic variability across human immune cell types","volume":"18","author":"Ecker","year":"2017","journal-title":"Genome Biol."},{"key":"10.1016\/j.jaut.2019.102305_bib60","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1159\/000493101","article-title":"Expanding neutrophil horizons: new concepts in inflammation","volume":"10","author":"Chatfield","year":"2018","journal-title":"J. Innate Immun."},{"key":"10.1016\/j.jaut.2019.102305_bib61","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.imbio.2012.10.007","article-title":"Activated phenotype of circulating neutrophils in familial Mediterranean fever","volume":"218","author":"Manukyan","year":"2013","journal-title":"Immunobiology"},{"key":"10.1016\/j.jaut.2019.102305_bib62","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/clpt.2013.148","article-title":"Novel therapeutics for the treatment of familial Mediterranean fever: from colchicine to biologics","volume":"95","author":"Grattagliano","year":"2014","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jaut.2019.102305_bib63","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.humimm.2010.11.006","article-title":"Evidence for the involvement of mTOR inhibition and basal autophagy in familial Mediterranean fever phenotype","volume":"72","author":"Mitroulis","year":"2011","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.jaut.2019.102305_bib64","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1126\/science.1092385","article-title":"Neutrophil extracellular traps kill bacteria","volume":"303","author":"Brinkmann","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.jaut.2019.102305_bib65","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/s41418-018-0261-x","article-title":"To NET or not to NET:current opinions and state of the science regarding the formation of neutrophil extracellular traps","volume":"26","author":"Boeltz","year":"2019","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.jaut.2019.102305_bib66","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1016\/j.cellsig.2013.08.038","article-title":"Regulated in DNA damage and development 1 (REDD1) promotes cell survival during serum deprivation by sustaining repression of signaling through the mechanistic target of rapamycin in complex 1 (mTORC1)","volume":"25","author":"Dennis","year":"2013","journal-title":"Cell. Signal."},{"key":"10.1016\/j.jaut.2019.102305_bib67","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.15252\/embj.201489920","article-title":"Che-1-induced inhibition of mTOR pathway enables stress-induced autophagy","volume":"34","author":"Desantis","year":"2015","journal-title":"EMBO J."},{"key":"10.1016\/j.jaut.2019.102305_bib68","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1093\/eurheartj\/ehv007","article-title":"Expression of functional tissue factor by neutrophil extracellular traps in culprit artery of acute myocardial infarction","volume":"36","author":"Stakos","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.jaut.2019.102305_bib69","first-page":"678","article-title":"NETopathies? Unraveling the dark side of old diseases through neutrophils","volume":"7","author":"Mitsios","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2019.102305_bib70","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1101\/gad.1617608","article-title":"Hypoxia regulates TSC1\/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling","volume":"22","author":"DeYoung","year":"2008","journal-title":"Genes Dev."},{"key":"10.1016\/j.jaut.2019.102305_bib71","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1093\/aje\/kwr460","article-title":"Triggers for attacks in familial Mediterranean fever: application of the case-crossover design","volume":"175","author":"Yenokyan","year":"2012","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.jaut.2019.102305_bib72","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/S0140-6736(84)92172-X","article-title":"Metaraminol provocative test: a specific diagnostic test for familial Mediterranean fever","volume":"1","author":"Barakat","year":"1984","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.jaut.2019.102305_bib73","article-title":"REDD1\/Autophagy pathway is associated with neutrophil-driven IL-1\u03b2 inflammatory response in active ulcerative colitis","volume":"2018","author":"Angelidou","year":"1950","journal-title":"J. Immunol. Baltim. Md"},{"issue":"Suppl 108","key":"10.1016\/j.jaut.2019.102305_bib74","first-page":"133","article-title":"Autophagy inhibition in adult-onset Still's disease: still more space for hydroxychloroquine?","volume":"35","author":"Papagoras","year":"2017","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2019.102305_bib75","doi-asserted-by":"crossref","DOI":"10.3899\/jrheum.181058","article-title":"Neutrophil extracellular traps may contribute to the pathogenesis in adult-onset Still's disease","author":"Ahn","year":"2019","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2019.102305_bib76","doi-asserted-by":"crossref","first-page":"546","DOI":"10.3389\/fimmu.2019.00546","article-title":"Skin and systemic inflammation in schnitzler's syndrome are associated with neutrophil extracellular trap formation","volume":"10","author":"Bonnekoh","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2019.102305_bib77","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2018-214335","article-title":"Critical role of neutrophil extracellular traps (NETs) in patients with Behcet's disease","author":"Le Joncour","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2019.102305_bib78","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1126\/science.aaa8064","article-title":"Inflammation. Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis","volume":"349","author":"Warnatsch","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.jaut.2019.102305_bib79","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029318","article-title":"Neutrophil extracellular trap formation is associated with IL-1\u03b2 and autophagy-related signaling in gout","volume":"6","author":"Mitroulis","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2019.102305_bib80","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nm.3547","article-title":"Aggregated neutrophil extracellular traps limit inflammation by degrading cytokines and chemokines","volume":"20","author":"Schauer","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.jaut.2019.102305_bib81","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1136\/annrheumdis-2018-213181","article-title":"REDD1\/autophagy pathway promotes thromboinflammation and fibrosis in human systemic lupus erythematosus (SLE) through NETs decorated with tissue factor (TF) and interleukin-17A (IL-17A)","volume":"78","author":"Frangou","year":"2019","journal-title":"Ann. Rheum. Dis."},{"issue":"2011","key":"10.1016\/j.jaut.2019.102305_bib82","first-page":"745","article-title":"Prevalence of MEFV gene mutations and their clinical correlations in Turkish children with Henoch-Sch\u00f6nlein purpura","volume":"100","author":"Bayram","year":"1992","journal-title":"Acta Paediatr. Oslo Nor."},{"key":"10.1016\/j.jaut.2019.102305_bib83","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1378\/chest.07-1736","article-title":"Unilateral lymphocytic pleuritis as a manifestation of familial Mediterranean fever","volume":"133","author":"Katsenos","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.jaut.2019.102305_bib84","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2016-216941","article-title":"Severe liver involvement in two patients with long-term history of fever: remember familial Mediterranean fever","volume":"2016","author":"Gatselis","year":"2016","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.jaut.2019.102305_bib85","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1007\/s10067-014-2602-6","article-title":"Clinical evaluation of R202Q alteration of MEFV genes in Turkish children","volume":"33","author":"Comak","year":"2014","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2019.102305_bib86","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.gene.2012.06.074","article-title":"Significance of MEFV gene R202Q polymorphism in Turkish familial Mediterranean fever patients","volume":"506","author":"Yigit","year":"2012","journal-title":"Gene"},{"key":"10.1016\/j.jaut.2019.102305_bib87","first-page":"489","article-title":"Anakinra suppresses familial Mediterranean fever crises in a colchicine-resistant patient","volume":"66","author":"Mitroulis","year":"2008","journal-title":"Neth. J. Med."},{"key":"10.1016\/j.jaut.2019.102305_bib88","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s10067-018-4230-z","article-title":"On demand use of anakinra for attacks of familial Mediterranean fever (FMF)","volume":"38","author":"Babaoglu","year":"2019","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2019.102305_bib89","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1136\/ard.2010.146878","article-title":"The efficacy of canakinumab in the treatment of a patient with familial Mediterranean fever and longstanding destructive arthritis","volume":"70","author":"Mitroulis","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2019.102305_bib90","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1136\/annrheumdis-2014-eular.2249","article-title":"Long-term therapy with canakinumab in two patients with refractory chronic autoinflammatory arthritis","volume":"73","author":"Skendros","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2019.102305_bib91","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00281-013-0361-0","article-title":"Neutrophils, IL-1\u03b2, and gout: is there a link?","volume":"35","author":"Mitroulis","year":"2013","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.jaut.2019.102305_bib92","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1002\/art.21061","article-title":"Rapid responses to anakinra in patients with refractory adult-onset Still's disease","volume":"52","author":"Fitzgerald","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2019.102305_bib93","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1136\/ard.2007.076034","volume":"67","author":"Lequerr\u00e9","year":"2008","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2019.102305_bib94","doi-asserted-by":"crossref","first-page":"R28","DOI":"10.1186\/ar2143","article-title":"A pilot study of IL-1 inhibition by anakinra in acute gout","volume":"9","author":"So","year":"2007","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2019.102305_bib95","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1136\/ard.2007.073759","article-title":"Management of treatment resistant inflammation of acute on chronic tophaceous gout with anakinra","volume":"66","author":"McGonagle","year":"2007","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2019.102305_bib96","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1056\/NEJMoa1205099","article-title":"Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis","volume":"367","author":"Ruperto","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2019.102305_bib97","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1136\/annrheumdis-2011-200908","article-title":"Canakinumab for acute gouty arthritis in patients with limited treatment options: results from two randomised, multicentre, active-controlled, double-blind trials and their initial extensions","volume":"71","author":"Schlesinger","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2019.102305_bib98","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41584-018-0081-x","article-title":"Mechanisms, biomarkers and targets for adult-onset Still's disease","volume":"14","author":"Feist","year":"2018","journal-title":"Nat. Rev. Rheumatol."},{"issue":"Suppl 1","key":"10.1016\/j.jaut.2019.102305_bib99","doi-asserted-by":"crossref","first-page":"eS17","DOI":"10.1016\/S1297-319X(15)30004-X","article-title":"Identifying patient candidates for IL-1 inhibition: lessons from real-world cases","volume":"82","author":"Avram","year":"2015","journal-title":"Jt. Bone Spine Rev. Rhum."},{"key":"10.1016\/j.jaut.2019.102305_bib100","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrrheum.2016.92","article-title":"Autophagy: controlling cell fate in rheumatic diseases","volume":"12","author":"Rockel","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jaut.2019.102305_bib101","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s13075-015-0775-2","article-title":"Enhanced activity of NLRP3 inflammasome in peripheral blood cells of patients with active rheumatoid arthritis","volume":"17","author":"Choulaki","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2019.102305_bib102","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1136\/gut.42.3.387","article-title":"Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history","volume":"42","author":"Orchard","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2019.102305_bib103","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/ecco-jcc\/jjy191","article-title":"The pathogenesis of extraintestinal manifestations: implications for IBD research, diagnosis, and therapy","volume":"13","author":"Hedin","year":"2019","journal-title":"J. Crohns Colitis."},{"key":"10.1016\/j.jaut.2019.102305_bib104","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-023765","article-title":"Trial summary and protocol for a phase II randomised placebo-controlled double-blinded trial of Interleukin 1 blockade in Acute Severe Colitis: the IASO trial","volume":"9","author":"Thomas","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.jaut.2019.102305_bib105","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/bjd.14685","article-title":"Successful response in a case of severe pustular psoriasis after interleukin-1\u03b2 inhibition","volume":"176","author":"Skendros","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jaut.2019.102305_bib106","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1146\/annurev-immunol-051116-052225","article-title":"Understanding human autoimmunity and autoinflammation through transcriptomics","volume":"35","author":"Banchereau","year":"2017","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jaut.2019.102305_bib107","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181874","article-title":"Clinical impact of a targeted next-generation sequencing gene panel for autoinflammation and vasculitis","volume":"12","author":"Omoyinmi","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2019.102305_bib108","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s00296-019-04252-5","article-title":"Diagnostic utility of a targeted next-generation sequencing gene panel in the clinical suspicion of systemic autoinflammatory diseases: a multi-center study","volume":"39","author":"Karacan","year":"2019","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jaut.2019.102305_bib109","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1002\/art.1780401023","article-title":"Criteria for the diagnosis of familial Mediterranean fever","volume":"40","author":"Livneh","year":"1997","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2019.102305_bib110","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.86336","article-title":"Anakinra as a diagnostic challenge and treatment option for systemic autoinflammatory disorders of undefined etiology","volume":"1","author":"Harrison","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.jaut.2019.102305_bib111","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.jaut.2019.102305_bib112","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.immuni.2019.03.012","article-title":"Interleukin-1 and related cytokines in the regulation of inflammation and immunity","volume":"50","author":"Mantovani","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2019.102305_bib113","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.clim.2019.04.004","article-title":"MCC950 blocks enhanced interleukin-1\u03b2 production in patients with NLRP3 low penetrance variants","volume":"203","author":"Schuh","year":"2019","journal-title":"Clin. Immunol. Orlando Fla."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841119304639?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841119304639?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:22:42Z","timestamp":1760257362000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841119304639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":113,"alternative-id":["S0896841119304639"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2019.102305","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoinflammation: Lessons from the study of familial Mediterranean fever","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2019.102305","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102305"}}